As we have seen, GLP-1 agonists have many benefits to help manage type 2 diabetes, curb appetite, slow down food movement, and feel fuller, so you eat less food, and very effective weight loss treatment
Financial Times reported this week that Lilly and Novo, the manufacturers of all four GLP-1 drugs commonly used for obesity therapy, are spending $3.5 billion this year to purchase smaller companies with promising anti-obesity therapies
Another oral, non-peptide GLP-1 RA (lotiglipron) has also been withdrawn from development as in early phase clinical trials resulted in elevated liver enzymes which could indicate liver toxicity [30]
In short: When your hormones are balanced, GLP-1 medications can do their jobhelping you lose fat, keep muscle, and feel your best